Literature DB >> 7682811

Particular ability of liver P450s3A to catalyze the oxidation of N omega-hydroxyarginine to citrulline and nitrogen oxides and occurrence in no synthases of a sequence very similar to the heme-binding sequence in P450s.

J P Renaud1, J L Boucher, S Vadon, M Delaforge, D Mansuy.   

Abstract

Liver microsomes from rats pretreated with various inducers of P450 isoforms exhibit very different abilities to catalyze the oxidation of N omega-hydroxy-L-arginine (NOHA) by NADPH and O2 with formation of citrulline and nitrogen oxides. Treatment of rats with dexamethasone, a classical inducer of P450 3A, leads to a spectacular 7-fold increase of the activity found for untreated rats, while induction by phenobarbital causes a much lower increase of this activity and induction by 3-methylcholanthrene or clofibrate decreases it. Specific inhibitors of P450s3A as troleandomycin and dihydroergotamine strongly inhibit NOHA oxidation whereas metyrapone, an inhibitor of other P450 subfamilies, was without effect. These data show the particular ability of P450s of the 3A subfamily to catalyze the second step of the oxidation of L-arginine by NO synthases (NOS). This analogy between NOSs and P450s3A is further substantiated by a protein sequence comparison which shows that a 9-amino acid segment present in all NOSs exhibits a strong similarity with the sequence mainly responsible for heme binding in P450s3A which is well conserved in all P450s. This segment contains all the structural factors which are thought to be crucial for heme binding in P450s.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682811     DOI: 10.1006/bbrc.1993.1380

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  In vitro metabolism of chlorpromazine by cytochromes P450 4F4 and 4F5 and the inhibitory effect of imipramine.

Authors:  C L Boehme; H W Strobel
Journal:  Neurotox Res       Date:  2001-08       Impact factor: 3.911

2.  Delineation of the arginine- and tetrahydrobiopterin-binding sites of neuronal nitric oxide synthase.

Authors:  A Boyhan; D Smith; I G Charles; M Saqi; P N Lowe
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Identification of the cysteine nitrosylation sites in human endothelial nitric oxide synthase.

Authors:  Monorama Tummala; Victor Ryzhov; Kandasamy Ravi; Stephen M Black
Journal:  DNA Cell Biol       Date:  2008-01       Impact factor: 3.311

4.  Inhibition of NO-medicate responses by 7-ethoxyresorufin, a substrate and competitive inhibitor of cytochrome P450.

Authors:  C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

5.  Molecular and biochemical characterization of dNOS: a Drosophila Ca2+/calmodulin-dependent nitric oxide synthase.

Authors:  M Regulski; T Tully
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

6.  Functional polymorphisms in CYP2C19 & CYP3A5 genes associated with decreased susceptibility for paediatric tuberculosis.

Authors:  Wei-Xing Feng; Fang Liu; Yi Gu; Wei-Wei Jiao; Lin Sun; Jing Xiao; Xi-Rong Wu; Qing Miao; Chen Shen; Dan Shen; Adong Shen
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

7.  Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer.

Authors:  P Klatt; K Schmidt; D Lehner; O Glatter; H P Bächinger; B Mayer
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.